Results 151 to 160 of about 5,882 (203)

Inhibition of Aurora B induces senescence and potentiates immunotherapy in hepatocellular carcinoma. [PDF]

open access: yesCell Oncol (Dordr)
Wu S   +8 more
europepmc   +1 more source

Proteasome: Role in T Cell Function Regulation. [PDF]

open access: yesInt J Biol Sci
Tang D, Wu X, Lei JH, Qiao Y, Deng CX.
europepmc   +1 more source

Immunoproteasome remodeling in senescing human macrophages reveals the loss of PA28αβ capping as a hallmark of immunosenescence. [PDF]

open access: yesCommun Biol
Monittola F   +13 more
europepmc   +1 more source

Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome. [PDF]

open access: yesAdv Sci (Weinh)
Demel UM   +19 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Immunoproteasomes and immunosenescence

Ageing Research Reviews, 2003
Aging is a complex process which is accompanied with the decline and the reshaping of different functions of the body. In particular the immune system is characterized, during ageing (immunosenescence) by a remodeling of innate immunity (well preserved, up-regulated) and clonotypical immunity (severely altered) and by the occurrence of a chronic ...
Mishto M.   +5 more
openaire   +3 more sources

Proteasomes and immunoproteasomes.

Rivista di biologia, 2011
In eukaryotic cells, the protein degradation is a highly regulated and selective process. Membrane-associated or extracellular proteins are degraded in lysosomes, whereas intracellular protein dismantling is primarily non-lysosomal, being realized by complex, not-membrane enclosed and energy-dependent effectors, the proteasomes, localized in both ...
Fietta, Pieranna, Delsante, Giovanni
openaire   +2 more sources

The immunoproteasome

American Journal of Transplantation, 2017
Modern treatment strategies for the maintenance of allograft acceptance frequently target ubiquitously-expressed pathways, leading to significant side-effects and poor long-term allograft outcomes. Constitutive proteasome inhibitors, which have recently been introduced for the treatment of antibody-mediated rejection, target the ubiquitously-expressed ...
Eskandari, S. K.   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy